Signaling angiogenesis via p42/p44 MAP kinase cascade

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 187-200

  Pagès, Gilles ^a   Milanini, Julie ^a   Richard, Darren E ^a   Berra, Edurne ^a   Gothié, Emmanuel ^a   Viñals, Francesc ^a   Pouysségur, Jacques ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANGIOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; GENE EXPRESSION REGULATION; HYPOXIA; ONCOGENE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0034098405     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06313.x     Document Type: Conference Paper

References (48)

1. 1. FOLKMAN, J. et al. 1971. Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133: 275-288.
2. 2. MUTHUKKARUPPAN, V. & R. AUERBACH. 1979. Angiogenesis in the mouse cornea. Science 205: 1416-1418.
3. 3. HANAHAN, D. & J. FOLKMAN. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
4. 4. BASILICO, C. & D. MOSCATELLI. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59: 115-165.
5. 5. FOLKMAN, J. & Y. SHING. 1992. Angiogenesis. J. Biol. Chem. 267: 10931-10934.
6. 6. LEUNG, D.W. et al. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
7. 7. BREIER, G. & W. RISAU. 1996. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell. Biol. 6: 454-456.
8. 8. RISAU, W. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
9. 9. COZZOLINO, F. et al. 1993. Interferon alpha and interleukin-2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J. Clin. Invest. 91: 2504-2512.
10. 10. TOI, M., A.L. HARRIS & R. BICKNELL. 1991. Interleukin-4 is a potent mitogen for capillary endothelium. Biochem. Biophys. Res. Commun. 174: 1287-1293.
11. 11. FERRARA, N. & W.J. HENZEL. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851-858.
12. 12. SHWEIKI, D. et al. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-945.
13. 13. TISCHER, E. et al. 1991. The human gene for vascular endothelial growth factor. J. Biol. Chem. 266: 11947-11954.
14. 14. BERSE, B. et al. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell. 3: 211-220.
15. 15. CARMELIET, P. et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
16. 16. FERRARA, N. et al. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
17. 17. SHALABY, F. et al. 1995. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376: 62-66.
18. 18. FONG, G.H. et al. 1995. Role of Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
19. 19. NEUFELD, G. et al. 1999. Vascular Endothelial Growth Factor (VEGF) and its receptors. FASEB J. 13: 9-22.
20. 20. SOKER, S. et al. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745.
21. 21. SATO, T.N. et al. 1995. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessels, formation. Nature 376: 70-74.
22. 22. DUMONT, D.J. et al. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor 3. Science 282: 946-949.
23. 23. FINKENZELLER, G., A. TECHNAU & D. MARME. 1995. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun. 208: 432-439.
24. 24. IKEDA, E. et al. 1995. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270: 19761-19766.
25. 25. LEVY, A.P., N.S. LEVY & M.A. GOLDBERG. 1996. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271: 2746-2753.
26. 26. WANG, G.L. & G.L. SEMENZA. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270: 1230-1237.
27. 27. SALCEDA, S. & J. CARO. 1997. Hypoxia inducible factor 1 alpha protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272: 22642-22647.
28. - dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95: 7987-7992.
29. 29. SEUWEN, K., A. LAGARDE & J. POUYSSÉGUR. 1988. Deregulation of hamster fibroblast proliferation by mutated ras oncogenes is not mediated by constitutive activation of phosphoinositide-specific phospholipase C. EMBO J. 7: 161-168.
30. 30. BRUNET, A., G. PAGES & J. POUYSSÉGUR. 1994. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9: 3379-3387.
31. 31. SAMUELS, M.L., J.M. WEBER & M. MCMAHON. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Biol. Cell. 13: 6241-6252.
32. 32. SAMUELS, M.L. & M. MCMAHON. 1994. Inhibition of platelet-derived growth factor and epidermal growth factor mediated mitogenesis and signalling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1. Mol. Biol. Cell. 14: 7855-7866.
33. 33. LENORMAND, P., M. MCMAHON & J. POUYSSÉGUR. 1996. Oncogenic Raf-1 activates p70 S6 kinase via mitogen-activated protein kinase-independent pathway. J. Biol. Chem. 271: 15762-15768.
34. 34. HAN, J. et al. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811.
35. 35. GALCHEVA-GARGOVA, Z. et al. 1994. An osmosensing signal transduction pathway in mammalian cells. Science 265: 806-808.
36. 36. DERIJARD, B. et al. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267: 682-685.
37. 37. RODRIGUEZ-VICIANA, P. et al. 1994. Phosphatidylinositol-3-OH kinase as a target of Ras. Nature 370: 527-532.
38. 38. KODAKI, T. et al. 1994. The activation of phosphatidyl 3-kinase by Ras. Curr. Biol. 4: 798-806.
39. 39. LEVY, A.P. et al. 1995. Transcriptional regulation of the rat vascular endothelial factor gene by hypoxia. J. Biol. Chem. 270: 13333-13340.
40. 40. KADONAGA, J.T. et al. 1987. Isolation of cDNA encoding transcription factor Sp-1 and functional analysis of the DNA binding domain. Cell 51: 1079-1090.
41. 41. HAGEN, G. et al. 1992. Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucl. Acids Res. 20: 5519-5525.
42. 42. SHIMA, D.T. et al. 1996. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of the transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271: 3877-3883.
43. 43. ANGEL, P. et al. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739.
44. 44. FORSYTHE, J.A. et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16: 4604-4613.
45. 45. MILANINI, J. et al. 1998. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem. 273: 18165-18172.
46. 46. RICHARD, D.E. et al. 1999. p42/p44 MAP kinases phosphorylate hypoxia inducible factor 1 alpha (HIF-1α) and enhance the transcriptional activity of HIF-1. J Biol. Chem. 274: 32631-32638.
47. 47. VINALS, F. & J. POUYSSÉGUR. 1999. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 Mitogen-Activated protein kinase activity. Mol. Cell. Biol. 19: 2763-2772.
48. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90: 8319-8323.